Atlas Trials

The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric Cancer

Clinical trial NCT03007446 · UNKNOWN

Trial details

NCT number
NCT03007446
Sponsor
Chinese PLA General Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2016-11-01
Primary completion
2018-11-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.